Dr. Dan Wallace Presents “New Therapies for Lupus and Clinical Trials” at Lupus LA's Annual Patient Education Conference

Systemic Lupus Erythematosus (SLE)

Disease Overview ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],¹U.S. Department of Health and Human Services. National Institutes of Health. National Institute of Arthritis and Musculoskeletal and Skin Diseases. NIH Publication No. 03-4178. August 2003. ²Lupus Foundation of America. Statistics About Lupus. Available at: http:// www.lupus.org/education/stats.htm.l . Accessed February 13, 2006. ³Werth, VP. Clinical manifestations of cutaneous lupus erythematosus. Autoimmunity Reviews 4 (2005) 296-302.

Pathogenesis ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],U.S. Department of Health and Human Services. National Institutes of Health. National Institute of Arthritis and Musculoskeletal and Skin Diseases. NIH Publication No. 03-4178. August 2003.

Drug-Induced Lupus ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],¹Kasper, DL, et al. Harrison’s Principle’s of Internal Medicine , 16 th edition. Chapter 300. 2005. ²Kauffman MD, CL. Lupus Erythematosus, Drug Induced. 2006. Available at: www.emedicine.com. Accessed February 13, 2006.

Common Signs & Symptoms of Lupus ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],U.S. Department of Health and Human Services. National Institutes of Health. National Institute of Arthritis and Musculoskeletal and Skin Diseases. NIH Publication No. 03-4178. August 2003.

Diagnostic Criteria ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Kasper, DL, et al . Harrison’s Principle’s of Internal Medicine , 16 th edition. Chapter 300. 2005.

Diagnosis ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],U.S. Department of Health and Human Services. National Institutes of Health. National Institute of Arthritis and Musculoskeletal and Skin Diseases. NIH Publication No. 03-4178. August 2003.

Monitoring Disease Progression ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],U.S. Department of Health and Human Services. National Institutes of Health. National Institute of Arthritis and Musculoskeletal and Skin Diseases. NIH Publication No. 03-4178. August 2003.

Proactive and Preventive Strategies in SLE ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Treatment ,[object Object],[object Object],[object Object],[object Object],[object Object],U.S. Department of Health and Human Services. National Institutes of Health. National Institute of Arthritis and Musculoskeletal and Skin Diseases. NIH Publication No. 03-4178. August 2003.

Current Therapies ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],U.S. Department of Health and Human Services. National Institutes of Health. National Institute of Arthritis and Musculoskeletal and Skin Diseases. NIH Publication No. 03-4178. August 2003 .

Other Therapies ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],U.S. Department of Health and Human Services. National Institutes of Health. National Institute of Arthritis and Musculoskeletal and Skin Diseases. NIH Publication No. 03-4178. August 2003.

New pathogenesis concepts since 2000 ,[object Object],[object Object],[object Object],[object Object]

New drug development in SLE ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Targets for New Therapies in SLE ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Dr. Dan Wallace Presents “New Therapies for Lupus and Clinical Trials” at Lupus LA's Annual Patient Education Conference

Recommandé

Recommandé

Contenu connexe

Tendances

Tendances (20)

En vedette

En vedette (14)

Similaire à Dr. Dan Wallace Presents “New Therapies for Lupus and Clinical Trials” at Lupus LA's Annual Patient Education Conference

Similaire à Dr. Dan Wallace Presents “New Therapies for Lupus and Clinical Trials” at Lupus LA's Annual Patient Education Conference (20)

Plus de LupusNY

Plus de LupusNY (20)

Dernier

Dernier (20)

Dr. Dan Wallace Presents “New Therapies for Lupus and Clinical Trials” at Lupus LA's Annual Patient Education Conference